Allergic bronchopulmonary aspergillosis, also known as allergic bronchopulmonary aspergillosis, is a highly reactive disease of the airways, mainly due to the obstruction of small organs after inhalation of large spores by aspergillus-allergic individuals, causing symptoms such as transient pulmonary atelectasis and wheezing episodes.
After a large number of spores are inhaled by the organism, mycotoxins and Aspergillus antigens are continuously produced in the airway. Aspergillus toxin can inhibit the activity of phagocytes, hindering their phagocytosis of Aspergillus and causing Aspergillus to colonize the airways. Aspergillus antigen can lead to inflammatory reactions in the airways and surrounding lung tissues through metamorphosis with the organism, eventually forming a series of pathological changes.
The main manifestations of this disease are wheezing, hemoptysis, mucopurulent sputum, fever, chest pain and coughing up brown sputum clots, etc. Relapses and remissions often alternate. Extrapulmonary dissemination can occur in a very small number of patients, such as the development of cerebral invasion, cerebrospinal fluid lymphocytosis, and pleural effusion.
Allergic bronchopulmonary aspergillosis is recommended to go to the hospital in time to clarify the cause of the disease, under the guidance of the doctor to follow the doctor’s prescription medication.